“Studying Injured Minds” – The Vietnam Head Injury Study and 40 Years of Brain Injury Research

Por Raymont, Vanessa, Salazar, Andres M., Krueger, Frank, Grafman, Jordan
Publicado em 2011

TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells

Por Ming Lim, Chwee, Stephenson, Ryan, Salazar, Andres M, Ferris, Robert L
Publicado em 2013

Complete Dependence on IRAK4 Kinase Activity in TLR2, but Not TLR4, Signaling Pathways Underlies Decreased Cytokine Production and Increased Susceptibility to Streptococcus pneumon...

Por Pennini, Meghan E., Perkins, Darren J., Salazar, Andres M., Lipsky, Michael, Vogel, Stefanie N.
Publicado em 2012

Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas

Por Okada, Hideho, Butterfield, Lisa H, Hamilton, Ronald L, Salazar, Andres M, Potter, Douglas M, Lieberman, Frank S, Pollack, Ian F
Publicado em 2013

Designing therapeutic cancer vaccines by mimicking viral infections

Por Sultan, Hussein, Fesenkova, Valentyna I., Addis, Diane, Fan, Aaron E., Kumai, Takumi, Wu, Juan, Salazar, Andres M., Celis, Esteban
Publicado no Cancer Immunol Immunother (2016)

TLR4 engagement during TLR3-induced pro-inflammatory signaling in dendritic cells promotes IL-10-mediated suppression of anti-tumor immunity

Por Bogunovic, Dusan, Manches, Olivier, Godefroy, Emmanuelle, Yewdall, Alice, Gallois, Anne, Salazar, Andres M, Marie, Isabelle, Levy, David E., Bhardwaj, Nina
Publicado em 2011

Dendritic cells require a systemic type I interferon response to mature and induce CD4(+) Th1 immunity with poly IC as adjuvant

Por Longhi, M. Paula, Trumpfheller, Christine, Idoyaga, Juliana, Caskey, Marina, Matos, Ines, Kluger, Courtney, Salazar, Andres M., Colonna, Marco, Steinman, Ralph M.
Publicado em 2009

Profound impairment of adaptive immune responses by alkylating chemotherapy

Por Litterman, Adam J., Zellmer, David M., Grinnen, Karen L., Hunt, Matthew A., Dudek, Arkadiusz Z., Salazar, Andres M., Ohlfest, John R.
Publicado em 2013

Poly-IC preconditioning protects against cerebral and renal ischemia-reperfusion injury

Por Packard, Amy E B, Hedges, Jason C, Bahjat, Frances R, Stevens, Susan L, Conlin, Michael J, Salazar, Andres M, Stenzel-Poore, Mary P
Publicado em 2012

Risk of Immunodeficiency Virus Infection May Increase with Vaccine-Induced Immune Response

Por Tenbusch, Matthias, Ignatius, Ralf, Temchura, Vladimir, Nabi, Ghulam, Tippler, Bettina, Stewart-Jones, Guillaume, Salazar, Andres M., Sauermann, Ulrike, Stahl-Hennig, Christiane, Überla, Klaus
Publicado em 2012

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

Por Kimura, Takashi, McKolanis, John R., Dzubinski, Lynda A., Islam, Kazi, Potter, Douglas M., Salazar, Andres M., Schoen, Robert E., Finn, Olivera J.
Publicado em 2012

Vaccine Injection Site Matters: Qualitative and Quantitative Defects in CD8 T Cells Primed as a Function of Proximity to the Tumor in a Murine Glioma Model

Por Ohlfest, John R., Andersen, Brian M., Litterman, Adam J., Junzhe, Xia, Pennell, Christopher A., Swier, Lauryn E., Salazar, Andres M., Olin, Michael R.
Publicado em 2012

Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population

Por Antonelli, Lis R.V., Gigliotti Rothfuchs, Antonio, Gonçalves, Ricardo, Roffê, Ester, Cheever, Allen W., Bafica, Andre, Salazar, Andres M., Feng, Carl G., Sher, Alan
Publicado em 2010

A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation

Por Vagenas, Panagiotis, Aravantinou, Meropi, Williams, Vennansha G., Jasny, Edith, Piatak, Michael, Lifson, Jeffrey D., Salazar, Andres M., Blanchard, James L., Gettie, Agegnehu, Robbiani, Melissa
Publicado em 2010

A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma(†)

Por Rosenfeld, Myrna R., Chamberlain, Marc C., Grossman, Stuart A., Peereboom, David M., Lesser, Glenn J., Batchelor, Tracy T., Desideri, Serena, Salazar, Andres M., Ye, Xiaobu
Publicado em 2010

Cytosolic receptor MDA5 mediates Poly-ICLC preconditioning induced neuroprotection against cerebral ischemic injury

Por Gesuete, Raffaella, Christensen, Sara N., Bahjat, Frances R., Packard, Amy E. B., Stevens, Susan L., Liu, Mingyue, Salazar, Andres M., Stenzel-Poore, Mary P.
Publicado no Stroke (2015)

Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis

Por Sionov, Edward, Mayer-Barber, Katrin D., Chang, Yun C., Kauffman, Keith D., Eckhaus, Michael A., Salazar, Andres M., Barber, Daniel L., Kwon-Chung, Kyung J.
Publicado no PLoS Pathog (2015)

Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion...

Por Kastenmüller, Kathrin, Espinosa, Diego A., Trager, Lauren, Stoyanov, Cristina, Salazar, Andres M., Pokalwar, Santosh, Singh, Sanjay, Dutta, Sheetij, Ockenhouse, Christian F., Zavala, Fidel, Seder, Robert A.
Publicado em 2013

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: A North American Brain Tumor Consortium (NABTC01-05)

Por Butowski, Nicholas, Chang, Susan M., Junck, Larry, DeAngelis, Lisa M., Abrey, Lauren, Fink, Karen, Cloughesy, Tim, Lamborn, Kathleen R., Salazar, Andres M., Prados, Michael D.
Publicado no J Neurooncol (2008)

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

Por Zhu, Xinmei, Nishimura, Fumihiko, Sasaki, Kotaro, Fujita, Mitsugu, Dusak, Jill E, Eguchi, Junichi, Fellows-Mayle, Wendy, Storkus, Walter J, Walker, Paul R, Salazar, Andres M, Okada, Hideho
Publicado em 2007